Medical device companies and industry groups spent nearly $32 million lobbying Congress during the third quarter.
Medical device industry lobbyists ramped up their spending during the 3rd quarter, dropping nearly $32 million on Washington in the 3 months ended Sept. 30.
The reports mark a continued incline for the industry's spending on Capitol Hill, which hit nearly $28 million last quarter and $20 million in Q1.
The American Medical Assn. led the charge in Q3, doling out more than $7 million, up from last quarter's $4.3 million.
Second in line was General Electric Co. (NYSE:GE) and its subsidiaries, including GE Healthcare, with $5.7 million. Last quarter the industry titan logged nearly $6.8 million in reported spending.
Coming in 3rd for the second quarter in a row, the Biotechnology Industry Organization spent $2.0 million in Q3, even with Q2. Novartis (NYSE:NVS) followed with $1.6 million, down from $1.9 million last quarter.
Med-tech giant Medtronic Inc. (NYSE:MDT) came in 5th, upping its lobbying spending to $1.3 million from last quarter's $1.2 million.
Here's a partial list of the medical device industry's 4th-quarter lobbying spend – including a $428,480 contribution from industry advocate AdvaMed: